Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.092 JPY | +0,83% | +3,02% | -12,78% |
15/02 | Takara Bio's toerekenbare inkomen daalt met 98,9% in fiscale negen maanden | MT |
2023 | Takara Bio Inc. Herziet de geconsolideerde winstverwachting voor het jaar dat eindigt op 31 maart 2024 | CI |
Vakgebied
Aantal werknemers: 1 793
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Reagent
84,4
%
| 54 605 | 80,7 % | 65 925 | 84,4 % | +20,73% |
Brokerage
10,5
%
| 11 426 | 16,9 % | 8 200 | 10,5 % | -28,23% |
Genetic Medicine
3,4
%
| 148 | 0,2 % | 2 640 | 3,4 % | +1.683,78% |
Equipment
1,8
%
| 1 518 | 2,2 % | 1 375 | 1,8 % | -9,42% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
58,4
%
| 34 076 | 50,3 % | 45 667 | 58,4 % | +34,02% |
United States
16,5
%
| 10 186 | 15,0 % | 12 886 | 16,5 % | +26,51% |
China
13,8
%
| 11 908 | 17,6 % | 10 799 | 13,8 % | -9,31% |
Europe
6,3
%
| 4 668 | 6,9 % | 4 949 | 6,3 % | +6,02% |
Asia excluding Japan and China
4,5
%
| 6 614 | 9,8 % | 3 546 | 4,5 % | -46,39% |
Others
0,4
%
| 244 | 0,4 % | 293 | 0,4 % | +20,08% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 68 | 01-06-14 | |
Koichi Nakao
PSD | President | 61 | 01-04-02 |
Takuya Kakemi
ADM | Chief Administrative Officer | - | - |
Junichi Mineno
COO | Chief Operating Officer | 63 | 01-04-04 |
Director/Board Member | 60 | 01-01-09 | |
Masanobu Kimura
BRD | Director/Board Member | 60 | 01-05-13 |
Human Resources Officer | - | - | |
Akihiko Kita
AUD | Comptroller/Controller/Auditor | 64 | 01-04-05 |
Corporate Officer/Principal | - | - | |
Masahide Tamaki
AUD | Comptroller/Controller/Auditor | 64 | 01-04-05 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hisashi Omiya
CHM | Chairman | 80 | 01-04-02 |
Masanobu Kimura
BRD | Director/Board Member | 60 | 01-05-13 |
Koichi Nakao
PSD | President | 61 | 01-04-02 |
Director of Finance/CFO | 68 | 01-06-14 | |
Director/Board Member | 60 | 01-01-09 | |
Junichi Mineno
COO | Chief Operating Officer | 63 | 01-04-04 |
Kazuko Kimura
BRD | Director/Board Member | 73 | 01-06-19 |
Nobuko Kawashima
BRD | Director/Board Member | 61 | 01-06-16 |
Director/Board Member | 52 | 01-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 120 415 600 | 47 065 600 ( 39,09 %) | 0 | 39,09 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Cellectis AB
Cellectis AB BiotechnologyHealth Technology Part of Takara Holdings, Inc., Cellectis AB is a Swedish company that manufactures and distributes stem cell-related products. The company is based in Gothenburg, Sweden. Cellectis was acquired by Takara Bio, Inc. from Cellectis SA on September 04, 2014. |
Biotechnology
|
Takara Bio Europe SAS
Takara Bio Europe SAS Medical SpecialtiesHealth Technology Takara BIO Europe SAS provides kits, reagents, instruments, and services that enable life sciences researchers to achieve their experimental objectives. It offers automation systems, stem cell research, real time PCR, nucleic acid purification, cloning, cell biology assays, gene function, antibodies, and ELISAs. The company is headquartered in Saint-Germain-en-Laye, France. |
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,78% | 836 mln. | |
+41,79% | 54,04 mld. | |
+45,77% | 41,96 mld. | |
-0,56% | 41,92 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+29,60% | 12,28 mld. | |
+24,91% | 12,19 mld. |
- Beurs
- Aandelen
- Koers 4974
- Onderneming Takara Bio Inc.